Shh signaling and pancreatic cancer: implications for therapy?
about
Cancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentSonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewalCSNK1A1 and Gli2 as Novel Targets Identified Through an Integrative Analysis of Gene Expression Data, Protein-Protein Interaction and Pathways Networks in Glioblastoma Tumors: Can These Two Be Antagonistic Proteins?Smoothened antagonist GDC-0449 (Vismodegib) inhibits proliferation and triggers apoptosis in colon cancer cell linesSonic hedgehog pathway expression in non-small cell lung cancerPDX-1: demonstration of oncogenic properties in pancreatic cancer.Two distinct sites in sonic Hedgehog combine for heparan sulfate interactions and cell signaling functions.The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis.α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis.Molecular changes in pancreatic cancer.Targeting Notch signaling in pancreatic cancer.Emerging pathways and future targets for the molecular therapy of pancreatic cancer.Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway.A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway.What's new in treatment of pancreatic cancer: a patent review (2010-2017).GLI2 inhibition abrogates human leukemia stem cell dormancy.Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells.Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer.
P2860
Q26740619-DCA350D3-8EED-4BB2-B2D3-CCCA8BFE68B6Q28484138-77A86493-873C-4372-80A4-ED7048BD3041Q30867941-B9637659-069D-44D9-A804-69FE22169D6FQ33723836-696FDD35-1B0B-4EF8-B6B4-53E056DB162BQ34401600-B2DF30F6-A108-4EDF-A9CB-F797D467DEDBQ34474763-0FE89E72-60DC-4652-824A-1A6870BA685AQ35639732-8B57F886-33A4-47A9-8E70-264B4BF007FEQ35914487-38FBBA47-EAF8-4B5B-8597-46DA4F619985Q35917482-FA8C796F-80F3-468F-A38F-D4337803E9A6Q37254268-F02F5AA7-C036-4824-8383-D94332EE9B5EQ37421292-57769CC3-AA18-40EC-A98C-949F5783C9E7Q37614592-1B08666B-3324-473C-8D34-09078A708906Q37730861-5FB44975-6F88-4C1F-B5FB-4F0D9D32C79CQ37912219-8D1E355A-87AE-46C7-BD23-DD368A6D0FCEQ38819847-271AA1F5-EC6F-40F3-9C64-4C0B9CD7D67EQ38920722-70633E28-AFF3-41B0-8D38-D8ACBFEF7EA9Q38961784-EB144A3F-2E91-4A56-BAF0-A48E74D5BFA9Q39203809-20CDE85B-6B25-4D06-9DA9-1EB7B2A21285Q39217952-E32446B3-746D-4B83-A243-1ACA2567E224Q39267979-2CFC2928-D8A8-4494-A65E-D9E85A73FBF8Q39372005-93CDF654-48B2-41F6-9C52-D01BE13882BCQ39406815-530D061B-2487-464F-980C-95B28912247BQ40079691-65A5A8BD-D98E-4F01-9F9A-9F4B6AEF8A0BQ41924355-53F11294-C7DE-4190-B07B-A72E2A056A9CQ42559903-4F2B9E7B-55F7-4F26-BFD8-83F2C73DFDA9Q54650155-E4370687-D2A8-4C8D-83BF-A35DCE309978
P2860
Shh signaling and pancreatic cancer: implications for therapy?
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Shh signaling and pancreatic cancer: implications for therapy?
@ast
Shh signaling and pancreatic cancer: implications for therapy?
@en
Shh signaling and pancreatic cancer: implications for therapy?
@nl
type
label
Shh signaling and pancreatic cancer: implications for therapy?
@ast
Shh signaling and pancreatic cancer: implications for therapy?
@en
Shh signaling and pancreatic cancer: implications for therapy?
@nl
prefLabel
Shh signaling and pancreatic cancer: implications for therapy?
@ast
Shh signaling and pancreatic cancer: implications for therapy?
@en
Shh signaling and pancreatic cancer: implications for therapy?
@nl
P356
P1433
P1476
Shh signaling and pancreatic cancer: implications for therapy?
@en
P2093
Brian C Lewis
P304
P356
10.4161/CC.6.13.4467
P577
2007-05-18T00:00:00Z